-
NextCure Inc. (NXTC $9.99)
- $9.99 Cap: $41M
- View NXTC Profile
- View Questions on NXTC
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Amgen Inc. (AMGN $347.80)
- $347.80 P/E (TTM): 24.7X Cap: $188.63B
- View AMGN Profile
- View Questions on AMGN
-
Regeneron Pharmaceuticals Inc. (REGN $732.87)
- $732.87 P/E (TTM): 17.94X Cap: $77.96B
- View REGN Profile
- View Questions on REGN
-
Vertex Pharmaceuticals Incorporated (VRTX $454.00)
- $454.00 P/E (TTM): 29.53X Cap: $116.36B
- View VRTX Profile
- View Questions on VRTX
-
iShares Biotechnology ETF (IBB $161.65)
- $161.65 P/E (TTM): 20.63X Cap: $7.93B
- View IBB Profile
- View Questions on IBB
-
Mettler-Toledo International Inc. (MTD $1,204.48)
- $1,204.48 P/E (TTM): 28.28X Cap: $24.10B
- View MTD Profile
- View Questions on MTD
-
Solid Biosciences Inc. (SLDB $7.03)
- $7.03 Cap: $554M
- View SLDB Profile
- View Questions on SLDB
-
TCR2 Therapeutics Inc. (TCRR)
-
NextCure Inc. (NXTC $9.99)
- $9.99 Cap: $41M
- View NXTC Profile
- View Questions on NXTC
Q: In an answer today you stated '20% of biotech companies in the US now trading below cash levels'. What would be your top biotech picks and/or your top biotech ETFs to play a recovery?
-
NextCure Inc. (NXTC $9.99)
- $9.99 Cap: $41M
- View NXTC Profile
- View Questions on NXTC
Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.
Insiders
Share Information
SEC Filings
News and Media